Marijuana is classified as Cannabis saiva L, one type of hemp. Traditionally, Marijuana is considered as Schedule I drug due to its acute bad effects on human health. However, its medical use has been widely recognized today. Delta-9-tetrahydrocannabinol ( 9 -THC) is a compound extracted from Marijuana, which has been used in several drugs approved by United States Food and Drug Administration (FDA).  9 -THC functions through cannabinoid receptor in neural system or peripheral tissues. For diabetes patients,  9 -THC has been reported to have preventative or treatment effects. In this paper, we will review recent research progress in association between cannabis use and diabetes, as well as known mechanism of how  9 -THC functions in human from the perspective of free radicals.
Introduction
Traditionally,federal laws classify marijuana as Schedule I (strictest) drug along with heroine and other hallucinogens by the Controlled Substances Act (1970) due to its high potency for abuse. Marijuana is known to cause a series of acute effects for the users [1] such as anxiety, impaired attention and short-term memory loss, as well as attenuated motor coordination, which pose risks in public settings, such as traffic accident. For longterm marijuana users, the impairment on cognition and memory could be prolonged and irreversible [2] . Once heavy marijuana users stopped its intake, they often experience persistent withdrawal symptoms such as nausea, insomnia and depression [2] . If not properly regulated, use of marijuana would cause tremendous social crisis and economic loss. Therefore, almost all countries have strict laws regulating use and usage of marijuana.
People often use the name hemp and marijuana interchangeably.The biological classification by the U.S. Department of Agriculture is that hemp is the common name for the genus called "Cannabis L." while marijuana referred to the species "Cannabis sativa L." Moreover, hemp contains only 0.3% of psychoactive chemicals and mainly planted for its strong fiber that can be used for building materials and textiles. Hemp seeds can also be used to produce hempseed oil which is a legal consumer product in the U.S and research has shown that hempseed oil is rich in essential fatty acids such as omega-6 and omega-3 believed by some as "super food" boasting beneficial effects against obesity, diabetes and arthritis. The U.S. imports around $500 million worth of hemp product annually from countries such as Canada and China, however, federal laws still prohibit growing of hemp in the U.S. In recent years, states legislatures have taken initiatives to endorse industrial hemp growth, so far 16 states allow industrial hemp growth and 20 states permit research use of hemp growth or pilot program for industrial hemp production. One the other hand, marijuana has about 10% on average of psychoactive chemicals, which is around 30 times higher than that is found in hemp. In addition, attempts have been made to appeal for reclassification of cannabis including marijuana. Marijuana is now legalized in eight states for adult recreational use; twenty-nine states and Washington, DC imposed laws for allowing medical use of marijuana.
Scientific research on cannabis and its extracted chemicals can be dated as early as 19 th century [3] . Until 1963, Mechoulam and coworkers [4] [5] [6] determined the structure and stereochemistry of the primary psychoactive component of cannabis, i.e. Zhang and coworkers recently reviewed extraction and analysis of  9 -THC [7] . So far, the FDA approved two synthetic cannabinoid prescription drugs that derived from  9 -THC, namely Marinol and Cesamet that can be used for treatment of nausea and neuropathic pain after cancer chemotherapy. Chemotherapy drugs, for example, cisplatin induces excessive inflammation and oxidative stress on kidney, renal and neuro system. Meng and coworkers [8] reported a phenolic aldehyde named protocatechuic aldehyde as antioxidant and possible suppress oxidative stress and inflammation poised by cisplatin, potentially operates in a similar fashion as  9 -THC. Extensive research has been carried out to elucidate the underlying nature for the psychoactive compound  9 -THC. In 1990, Matsuda and coworkers [9] reported for the first time the THC receptor in mouse brain cells is a G-protein coupled receptor and isolated a complementary DNA sequence that later used to clone the cannabinoid ( 9 -THC) receptor. Gerard and coworkers [10] were able to clone a human cannabinoid receptor using human brain stem cell cDNA. To illuminate the native function of the cannabinoid receptor in the brain, Mechoulam and coworkers [11] isolated and identified the endogenous ligand for the cannabinoid receptor to be anandamide that could act as neurotransmitter for controlling of pleasure. Munro and coworkers [12] reported finding of cannabinoid receptor in the peripheral immune systems such as macrophage cells. The cannabinoid receptors found in the brain as well as central neural systems are often named as CB1 and the ones found in peripheral tissues for controlling of inflammation and immunological reactions are classified as CB2. 
2.Main text

2.1Diabetes as the No.1 health risk
With the legalization of cannabis and related product, it is necessary to review some of the health consequences for people with regular intake of marijuana. We hereby focus on the recent research data between cannabis product and incidents of diabetes mellitus. Diabetes is becoming the most expensive disease in the U.S., costing over $100 billion for diagnosis and treatment per year since 2013 [13] . As of 2014, centers for disease control and prevention (CDC) published statistic data of total diabetes patients in the U.S. to be around 29 million, over 80 million people have prediabetes. Recent advancement in portable personal electronic monitoring device helped with diagnosis of prediabetes [14] [15] [16] . The total number of diabetes patients in the world was estimated to be around 285 million; the number is projected to be more than 438 million by 2030, Table 1 [17] . Diabetes mellitus can be classified as type 1 and type 2. Type 1 diabetes arises from auto immune disorders led by destruction of insulin secretary pancreatic beta-cells [17] . From a geographical perspective, the prevalence of type 1 diabetes is higher in area with less sunlight such as Finland and lower in area with more sunlight, e.g. India. Furthermore, more cases of type 1 diabetes were diagnosed in winter where sunlight is minimal. This trend is similar to what was found for people with less vitamin D 3 synthesis by their skin cells where exposure to sunlight radiation was at reduced amount and higher incidence of cancer, for example [18, 19] . From a genetic perspective, certain mutations or disruption of DNA nucleotide base pairs [20] , for example, single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (an enzyme found to attenuate T-cell activation) [21] are associated with type 1 diabetes. The cause of type 2 diabetes is complex and can be attributed to many factors such as high-energy diet and lack of exercise. Wang and coworkers [22] reported inhibition of tyrosine phosphatase enhances insulin sensitivity and could provide therapeutic potential for type 2 diabetes. Cruz and coworkers [23] reported glycine (amino acid normally exists in microhydrated zwitterionic form [24] ) could increase insulin sensitivity and reduce level of glycated hemoglobin.
2.2Epidemiological studies that link cannabinoid and decreased diabetes
Epidemiological studies have linked decreased diabetes incidence with the use of cannabinoid. In 2012, Rajavashisth and coworkers [25] analyzed data collected by the National Health and Nutrition Examination Survey and found that current light marijuana users have lower diabetes prevalence than current heavy users and past marijuana users, Figure 2 . Also, all marijuana users (past or current) are less likely to be diagnosed as diabetes compared to non-marijuana users ( Figure  2 ) after adjustment with confronting factors such as age, race and alcohol use. Using logistic regression assessment of the data, the odds ratio (OR) for current light users is 0.29 (95% CI 0.13 to 0.65) compared to non-users. Past marijuana users have odds ratio of 0.44 (95% CI 0.33 to 0.59) and current heavy users have odds ratio of 0.47 (95% CI 0.22 to 0.98) then non-marijuana users, Figure 2 . Later in 2013, Mittleman and coworkers [26] analyzed data from the National Health and Nutrition Examination Survey (NHANES) including 4657 adult men and women from 2005 and 2010. They reported that the correlation between marijuana use and lower fasting insulin level and less insulin resistant is statistically significant, Table 2 . The current marijuana users have lower insulin level (7.5 U/mL) than nonusers (10.1 U/ml) on average while past users have insulin level between the two groups (8.8 U/ml). Glucose level is also higher for the non-users (103.5 mg/dL) than current marijuana users (99.7 mg/dL) and for past users the level is (100.6 mg/dL). Homeostasis model assessment of insulin resistant (HOMA-IR) is again lower for current marijuana users (1.8) when compared to past users (2.2) and non-users (2.5).
The hemoglobin A1c (HbA1c), triglycerides and high-density lipoprotein cholesterol (HDL-C) levels are similar for current, past and nonmarijuana users. Body mass index (BMI) is higher for non-marijuana users (29.1 kg/m 2 ) the number found in past marijuana users (28.5 kg/m 2 ) as well as current marijuana user (27.2 kg/m 2 ). Current marijuana users also tend to have smaller waist circumference (93.6 cm) than past marijuana users (97.6 cm) and non-marijuana users. HOMA-IR = homeostasis model assessment of insulin resistance; HbA1c = hemoglobin A1c; HDL-C = high-density lipoprotein cholesterol; BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure. *Means for insulin, HOMA-IR and triglycerides are geometric.
Anthony and coworkers [27] analyzed data from both National Health and Nutrition Examination Survey (NHANES) as well as the National Surveys on Drug Use and Health (NSDUH) using eight independent sample pools, Table 3 and found that the unadjusted odds ratio of marijuana users to have diabetes mellitus is 0.4 (95% CI, 0.3 -0.5) averaging, Table 3 . After adjustments for age, sex, ethnics, education, income, alcohol and cigarette smoking, the odds ratio of marijuana users to have diabetes mellitus is 0.7 (95% CI 0.6 -0.8) which is still statistically lower than non-marijuana users to develop diabetes mellitus.
Agardh
and coworkers [28] gathered longitudinal data by questionnaires for about 18,000 Swedish men and women and reported marijuana users had lower risk of type 2 diabetes with odds ratio = 0.68 (95% CI 0.47 to 0.99). In addition, Agardh and coworkers computed the odds ratio fell to 0.94 (95% CI 0.63 to 1.39) after adjustment for age, Table 4 . However, in their adjusted odds ratio 0.94 (95% CI 0.63 to 1.39), they did not differentiate current marijuana users or past marijuana population. In fact, Agardh and coworkers did mention in the paper that the odds ratio is 0.97 for people who used marijuana more than one year ago and the same odds ratio fell to 0.74 when combining the cases in which people used marijuana in the past month or the past year. This result is actually similar to what Anthony and coworkers [28] obtained when they studied data from the National Health and Nutrition Examination Survey (NHANES) and the National Surveys on Drug Use and Health (NSDUH) and obtained the adjusted odds ratio 0.7 (95% CI 0.6 -0.8). Therefore, based on the lengthened epidemiological studies, marijuana did show at least protective effects again diabetes mellitus.
The role of Cannabinoid and cannabidiol as antioxidant
Unhealthy diets usually contain high sugar and energy; the resulting energy surplus can impose great oxidative and nitrosative stress on metabolism. Reactive oxygen species are often generated by molecular oxygen binding to redox active metals such as copper and iron in the human body as side product for energy production. Formation and reactivity of reactive oxygen species are well characterized in ligand copper oxygen model chemistry, for example [29] [30] [31] . Inoguchi and coworkers [32] reported that high glucose level significantly increases reactive oxygen species production in cultured smooth muscle cells (SMCs) and endothelial cells (ECs) detected by electron spin resonance spectroscopy. Rosen and Lander and coworkers [33] examined the causal effects of reactive oxygen species on the insulin resistant and found that reduced level of reactive oxygen species greatly enhances insulin sensitivity. Insulin resistant is generally considered as the major hallmark of type 2 diabetes. Therefore, reactive oxygen species play a significant role in the development of type 2 diabetes. a Covariate adjustments for age (years), sex (male and female), ethnic self-identification (non-Hispanic Whites, nonHispanic Blacks, Hispanics, and all others), education (less than high school, high school, and above high school), income-poverty ratio (<1 and ≥1), past-year alcohol drinking (never user, used before but not in the 12 months prior to the interview, and used in the 12 months prior to the interview) and tobacco cigarette smoking (never, former, nondaily, and daily smoker), using the multiple logistic regression model. b Additionally adjusted for BMI (kg/m 2 ). The NSDUH study does not collect data on BMI.
c This 'random effects' meta-analysis summary estimate makes an allowance for between-replication variability in the effect estimates. The heterogeneity test statistic (degrees of freedom =7) suggests no appreciable variation (i.e., as gauged in relation to alpha set at 0.05); nonetheless, the 'random effects' summary estimate was retained, with resulting standard errors (and 95% CI) slightly larger than those obtained using the 'fixed effects' meta-analysis summary estimation approach. Cannabinoids were compared with BHT (butylated hydroxytoluene, a common antioxidant) for their ability to prevent tert-butyl hydroperoxideinduced oxidation of dihydrorhodamine. Data represent mean values SEM from a single experiment with three replicates. This experiment was repeated four times with essentially the same results [34] . The neuroprotective roles of cannabinoid ( 9 -THC) and cannabidiol (CBD) have long been reported as antioxidant against reactive oxygen and nitrogen species. Hampson and coworkers [34] reported the protective role of cannabidiol and cannabinoid against hydrogen peroxide [34] where tert-butyl hydroperoxide-induced toxicity was examined in the presence of cannabidiol. The y-axis represents lactate dehydrogenase (LDH) released into the media by dying cells in percentage against control group. Cannabidiol ( 9 -THC) exhibits half maximal effective concentration (EC 50 ) to be 6.2 ± 0.1 M and the maximum protective effect again hydrogen peroxide is around 90%. In a separate experiment, Hampson and coworkers [34] tested cannabinoid ( 9 -THC), cannabidiol (CBD) and butylated hydroxytoluene (BHT, a common antioxidant) for their ability to prevent tert-butyl hydroperoxide-induced oxidation of dihydrorhodamine, which is a fluorescent reagent for detection of reactive oxygen species [34] . Cannabinoid ( 9 -THC) is shown as effective as NHT with half maximal effective concentration (EC 50 ) to be 18 ± 1 M which cannabidiol (CBD) is more effective with half maximal effective concentration (EC 50 ) to be 11 ± 1 M [34] . In addition, both cannabinoid ( 9 -THC) and cannabidiol (CBD) have shown protective roles against toxic amount of glutamate, which is an important neurotransmitter [34] . Downregulation mechanism for cannabinoid ( 9 -THC) and cannabidiol (CBD) have been proposed by Jourdan and coworkers [35] on the cannabinoid receptors. This means rather than activation of CB1 receptor, cannabinoid ( 9 -THC) was shown to desensitize the cannabinoid receptors and exhibited protective effects of chronic cannabinoid ( 9 -THC) administration.
4.Anti-inflammatory role of cannabidiol
Type 1 diabetes is an autoimmune disorder disease led by immune-associated destruction of insulin-producing pancreatic β cells [17] . Immune system can be activated by inducible nitric oxide synthase (iNOS) [36] upon invading pathogens or NO x pollution in the atmosphere [37] . Nitric oxide is also a signaling agent and it can be detected via a number of spectroscopic techniques [38] . However, excessive nitric oxide production can lead to tissue damaging effects via formation of reactive nitrogen species. In the case of inflammation and immune reactions, reactive nitrogen species are generated and could result in post-translational modification on protein, lipids and DNAs. One example is shown as tyrosine nitration imposed by iron or copper peroxynitrite complex [31, 39, 40] . Weiss and coworkers reported [41] that treating type 1 diabetes prone mice with 5 mg/kg of cannabidiol (CBD) significantly reduce occurrences of type 1 diabetes, compared to vehicle control and untreated mice, Figure 3 . Figure 3 . Incidence of diabetes in NOD mice treated with 5 mg/kg of CBD, vehicle control and untreated mice. The incidence of diabetes in the CBD treated group, compared with vehicle-treated mice and untreated controls was significant p<0.001 (log tank test) [41] After about 21 weeks, untreated mice all developed diabetes while over 80% of vehicletreated mice have also developed diabetes, Figure 3 . With CBD treated group, the incidence of diabetes mice plateaued at 18 weeks and only 30% mice developed diabetes through 25 weeks, Figure 3 . Since cannabidiol is neither agonist or antagonist for the cannabinoid receptor, a cannabinoid receptor-independent mechanism was proposed for the protective effects of cannabidiol [35] .
Summary
Recent research of cannabis products has shed light on diabetes diseases, though researchers and pharmaceutical companies are still cautious due to strict federal law regulation and traditional opinion of these products. Decreased prevalence of diabetes was found in current light marijuana users, compared to current heavy users and past users. Lower fasting insulin level and less insulin resistance was correlated with marijuana use. To pursue the mechanism of how marijuana protects human from diabetes, Delta-9-tetrahydrocannabinol ( 9 -THC) and cannabidiol were brought into researchers' attention. Reduced reactive oxygen species are found to greatly enhance insulin sensitivity. Insulin resistance is a major hallmark of type 2 diabetes.  9 -THC has been repeatedly reported as antioxidant against reactive oxygen species and nitrogen species, such as hydrogen peroxide. Emulsifier (21) Ctrl (21) desensitize the cannabinoid receptor and exhibited protective effects of chronic cannabinoid administration. The diabetic syndromes were significantly relieved in diabetic type 1 mice after treatment of cannabidiol. All these evidences have shown promising medical effect of THC and cannabidiol. Further work may focus on further elucidation of mechanisms, toxicity of different doses and clinical trials.
